Kiniksa Pharmaceuticals International (KNSA) Equity Ratio (2021 - 2025)
Kiniksa Pharmaceuticals International's Equity Ratio history spans 5 years, with the latest figure at 0.74 for Q4 2025.
- For Q4 2025, Equity Ratio fell 1.58% year-over-year to 0.74; the TTM value through Dec 2025 reached 0.74, down 1.58%, while the annual FY2025 figure was 0.74, 1.58% down from the prior year.
- Equity Ratio reached 0.74 in Q4 2025 per KNSA's latest filing, down from 0.75 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.88 in Q1 2023 to a low of 0.72 in Q1 2022.
- Average Equity Ratio over 5 years is 0.8, with a median of 0.82 recorded in 2024.
- Peak YoY movement for Equity Ratio: dropped 17.26% in 2022, then increased 22.38% in 2023.
- A 5-year view of Equity Ratio shows it stood at 0.79 in 2021, then grew by 8.43% to 0.86 in 2022, then fell by 3.25% to 0.83 in 2023, then decreased by 9.42% to 0.76 in 2024, then fell by 1.58% to 0.74 in 2025.
- Per Business Quant, the three most recent readings for KNSA's Equity Ratio are 0.74 (Q4 2025), 0.75 (Q3 2025), and 0.75 (Q2 2025).